Skip Navigation


JAC Advance Access originally published online on November 28, 2008
Journal of Antimicrobial Chemotherapy 2009 63(2):389-395; doi:10.1093/jac/dkn489
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
63/2/389    most recent
dkn489v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrow Disclaimer
Google Scholar
Right arrow Articles by McMurdo, M. E. T.
Right arrow Articles by Davey, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McMurdo, M. E. T.
Right arrow Articles by Davey, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org


Original research

Cranberry or trimethoprim for the prevention of recurrent urinary tract infections? A randomized controlled trial in older women

Marion E. T. McMurdo1,*, Ishbel Argo1, Gabby Phillips2, Fergus Daly3 and Peter Davey3

1 Ageing and Health, Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, Scotland, UK 2 Department of Medical Microbiology NHS Tayside, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, Scotland, UK 3 Mackenzie Building, Division of Community Health Sciences, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, Scotland, UK

Received 22 July 2008; returned 30 October 2008; revised 5 November 2008; accepted 5 November 2008


* Corresponding author. E-mail: m.e.t.mcmurdo{at}dundee.ac.uk

Objectives: To compare the effectiveness of cranberry extract with low-dose trimethoprim in the prevention of recurrent urinary tract infections (UTIs) in older women.

Patients and methods: One hundred and thirty-seven women with two or more antibiotic-treated UTIs in the previous 12 months were randomized to receive either 500 mg of cranberry extract or 100 mg of trimethoprim for 6 months. Trial registration: ISRCTN80031108 [controlled-trials.com] .

Results: Thirty-nine of 137 participants (28%) had an antibiotic-treated UTI (25 in the cranberry group and 14 in the trimethoprim group); difference in proportions relative risk 1.616 (95% CI: 0.93, 2.79) P = 0.084. The time to first recurrence of UTI was not significantly different between the groups (P = 0.100). The median time to recurrence of UTI was 84.5 days for the cranberry group and 91 days for the trimethoprim group (U = 166, P = 0.479). There were 17/137 (12%) withdrawals from the study, 6/69 (9%) from the cranberry group and 11/68 (16%) from the trimethoprim group (P = 0.205), with a relative risk of withdrawal from the cranberry group of 0.54 (95% CI: 0.19, 1.37).

Conclusions: Trimethoprim had a very limited advantage over cranberry extract in the prevention of recurrent UTIs in older women and had more adverse effects. Our findings will allow older women with recurrent UTIs to weigh up with their clinicians the inherent attractions of a cheap, natural product like cranberry extract whose use does not carry the risk of antimicrobial resistance or super-infection with Clostridium difficile or fungi.

Keywords: urinary infections , UTIs , antibiotics


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Gerontol A Biol Sci Med SciHome page
S. Zou, J. R. Carey, P. Liedo, D. K. Ingram, B. Yu, and R. Ghaedian
Prolongevity Effects of an Oregano and Cranberry Extract are Diet Dependent in the Mexican Fruit Fly (Anastrepha ludens)
J Gerontol A Biol Sci Med Sci, November 11, 2009; (2009) glp176v1.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
M. S. Dryden, J. Cooke, and P. Davey
Antibiotic stewardship--more education and regulation not more availability?
J. Antimicrob. Chemother., November 1, 2009; 64(5): 885 - 888.
[Abstract] [Full Text] [PDF]


Home page
Age AgeingHome page
D. Sumukadas, P. Davey, and M. E. T. McMurdo
Recurrent urinary tract infections in older people: the role of cranberry products
Age Ageing, May 1, 2009; 38(3): 255 - 257.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.